Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Apogee Therapeutics Inc | 8,493,321 | 8,493,321 | 0 | $384.75M | $317.31M | 27.00% | -$67.44M |
| Metsera Inc | 0 | 3,750,662 | +3,750,662 | $0 | $102.09M | 8.69% | +$102.09M |
| Ocular Therapeutix, Inc.(OCUL) | 12,762,462 | 12,762,462 | 0 | $108.99M | $93.55M | 7.96% | -$15.44M |
| Enliven Therapeutics Inc | 4,026,331 | 4,026,331 | 0 | $90.59M | $79.24M | 6.74% | -$11.35M |
| Kalvista Pharmaceuticals Inc | 6,249,731 | 6,703,985 | +454,254 | $52.94M | $77.36M | 6.58% | +$24.43M |
| Viridian Therapeutics, Inc.(VRDN) | 3,882,709 | 3,882,709 | 0 | $74.43M | $52.34M | 4.45% | -$22.09M |
| Pharvaris N V COM | 3,220,130 | 3,112,720 | -107,410 | $61.73M | $48.87M | 4.16% | -$12.86M |
| Spyre Therapeutics, Inc.(SYRE) | 2,685,448 | 2,685,448 | 0 | $62.52M | $43.33M | 3.69% | -$19.19M |
| Oruka Therapeutics, Inc.(ORKA) | 3,285,620 | 4,148,428 | +862,808 | $63.71M | $42.56M | 3.62% | -$21.15M |
| Praxis Precision Medicines, Inc.(PRAX) | 989,985 | 989,985 | 0 | $76.19M | $37.49M | 3.19% | -$38.70M |
| Cogent Biosciences, Inc.(COGT) | 5,684,411 | 5,684,411 | 0 | $44.34M | $34.05M | 2.90% | -$10.29M |
| Dianthus Therapeutics, Inc.(DNTH) | 1,744,373 | 1,744,373 | 0 | $38.03M | $31.64M | 2.69% | -$6.38M |
| Dyne Therapeutics, Inc.(DYN) | 2,173,913 | 2,173,913 | 0 | $51.22M | $22.74M | 1.93% | -$28.48M |
| Cidara Therapeutics Inc | 765,723 | 1,051,518 | +285,795 | $20.58M | $22.65M | 1.93% | +$2.07M |
| Engene Holdings Inc COM | 5,046,414 | 5,046,414 | 0 | $33.56M | $22.61M | 1.92% | -$10.95M |
| Erasca, Inc.(ERAS) | 16,216,216 | 16,216,216 | 0 | $40.70M | $22.22M | 1.89% | -$18.49M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 4,394,527 | 3,182,527 | -1,212,000 | $35.46M | $17.76M | 1.51% | -$17.71M |
| Upstream Bio, Inc.(UPB) | 2,295,319 | 2,295,319 | 0 | $37.74M | $14.05M | 1.20% | -$23.69M |
| Astria Therapeutics Inc | 2,457,348 | 2,457,348 | 0 | $21.97M | $13.12M | 1.12% | -$8.85M |
| Cullinan Therapeutics, Inc.(CGEM) | 1,379,965 | 1,379,965 | 0 | $16.81M | $10.45M | 0.89% | -$6.36M |
| Solid Biosciences Inc | 0 | 2,481,400 | +2,481,400 | $0 | $9.18M | 0.78% | +$9.18M |
| Savara Inc.(SVRA) | 0 | 3,257,639 | +3,257,639 | $0 | $9.02M | 0.77% | +$9.02M |
| ABIVAX Société AnonymeADS(ABVX) | 1,345,780 | 1,345,780 | 0 | $9.85M | $8.41M | 0.72% | -$1.44M |
| Perceptive Cap Solutions CorCL A CL A ORD SHS | 750,000 | 750,000 | 0 | $7.63M | $7.72M | 0.66% | +$90.0K |
| Surrozen, Inc.(SRZN) | 0 | 632,931 | +632,931 | $0 | $7.38M | 0.63% | +$7.38M |
| Zura Bio LimitedCL A(ZURA) | 2,023,166 | 5,023,166 | +3,000,000 | $5.06M | $6.48M | 0.55% | +$1.42M |
| Artiva Biotherapeutics, Inc.(ARTV) | 1,609,569 | 1,609,569 | 0 | $16.22M | $4.83M | 0.41% | -$11.40M |
| Trevi Therapeutics, Inc.(TRVI) | 1,266,457 | 615,506 | -650,951 | $5.22M | $3.87M | 0.33% | -$1.35M |
| Applied Therapeutics Inc | 9,990,591 | 5,567,709 | -4,422,882 | $8.55M | $2.72M | 0.23% | -$5.83M |
| 4d Molecular Therapeutics In | 2,952,371 | 677,600 | -2,274,771 | $16.44M | $2.19M | 0.19% | -$14.26M |
| CASI Pharmaceuticals, Inc.(CASIF) | 987,259 | 987,259 | 0 | $2.79M | $2.13M | 0.18% | -$661.5K |
| Tenax Therapeutics, Inc.(TENX) | 208,333 | 208,333 | 0 | $1.29M | $1.36M | 0.12% | +$75.0K |
| Mersana Therapeutics Inc | 10,257,790 | 3,574,325 | -6,683,465 | $14.67M | $1.23M | 0.10% | -$13.44M |
| Century Therapeutics, Inc.(IPSC) | 3,957,186 | 2,498,069 | -1,459,117 | $4.00M | $1.19M | 0.10% | -$2.81M |
| Tenaya Therapeutics, Inc.(TNYA) | 1,555,556 | 1,555,556 | 0 | $2.22M | $886.8K | 0.08% | -$1.34M |
| Glycomimetics Inc | 3,000,000 | 3,000,000 | 0 | $747.0K | $630.0K | 0.05% | -$117.0K |
| Instil Bio, Inc.(TIL) | 33,177 | 33,177 | 0 | $633.3K | $576.0K | 0.05% | -$57.4K |
| Aquestive Therapeutics Inc | 2,629,786 | 0 | -2,629,786 | $9.36M | $0 | — | -$9.36M |
| Merus N V | 592,411 | 0 | -592,411 | $24.91M | $0 | — | -$24.91M |
| Taysha Gene Therapies, Inc.(TSHA) | 3,225,180 | 0 | -3,225,180 | $5.58M | $0 | — | -$5.58M |
| Terns Pharmaceuticals Inc | 1,077,090 | 0 | -1,077,090 | $5.97M | $0 | — | -$5.97M |